Prognostic value DCE-MRI parameters in predicting factor disease free survival and overall survival for breast cancer patients

European Journal of Radiology

Volumn 81, Issue 5, 2012, Pages 863-867

  Tuncbilek, Nermin ^a   Tokatli, Fusun ^b   Altaner, Semsi ^c   Sezer, Atakan ^c   Türe, Mevlüt ^d   Omurlu, Imran Kurt ^d   Temizoz, Osman ^a  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Medicana International Istanbul   (Turkey)

^c TRAKYA UNIVERSITY   (Turkey)

^d ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Breast cancer; DCE MRI; Empirical analysis; Prognosis; Survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TURKEY;

EID: 84859984907     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.02.021     Document Type: Article

References (32)

1. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220:13-30. (Pubitemid 32577955)
2. Cross MJ, Harms SE, Cheek JH, Peters GN, Jones RC. New horizons in the diagnosis and treatment of breast cancer using magnetic resonance imaging. Am J Surg 1993;166:749-53.
3. Szabo BK, Aspelin P, Wiberg MK, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425-35. (Pubitemid 37407473)
4. Kitagawa K, Sakuma H, Ishida N, Hirano T, Ishihara A, Takeda K. Contrast-enhanced high-resolution MRI of invasive breast cancer: correlation with histopathologic subtypes. AJR 2004;183:1805-9. (Pubitemid 44210562)
5. Nagashima T, Suzuki M, Yagata H, et al. Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer. Breast Cancer 2002;9:226-30.
6. Turetschek K, Huber S, Floyd E, et al. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 2001;218:562-9. (Pubitemid 32121076)
7. Neubauer H, Li M, Kuehne-Heid R, Schneider A, Kaiser WA. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 2003;76:3-12. (Pubitemid 36236293)
8. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-10. (Pubitemid 29161739)
9. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 1994;193:239-45.
10. Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, Su MY. Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol 2008;19:822-4. (Pubitemid 351461058)
11. Bone B, Aspelin P, Bronge L, Veress B. Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 1998;39:279-84. (Pubitemid 128452467)
12. Mussurakis S, Buckley DL, Horsman A. Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 1997;70:446-51. (Pubitemid 27229263)
13. Narisada H, Aoki T, Sasaguri T, et al. Correlation between numeric gadolinium-enhanced dynamic MRI ratios and prognostic factors and histologic type of breast carcinoma. AJR 2006;187:297-306. (Pubitemid 44148270)
14. Bone B, Szabo BK, Perbeck LG, et al. Can contrast-enhanced MR imaging predict survival in breast cancer? Acta Radiol 2003;44:373-8.
15. Pickles MD, Manton DJ, Lowry M, Turnbull LW. Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy. Eur J Radiol 2009;71:498-505.
16. Yuh WT, Mayr NA, Jarjoura D, et al. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol 2009;44:343-50.
17. Tuncbilek N, Karakas HM, Okten OO. Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. Eur J Radiol 2005;53:199-205. (Pubitemid 40143581)
18. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996;2000:639-49.
19. Reddick WE, Wang S, Xiong X, et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer 2001;91:2230-7. (Pubitemid 32552807)
20. Frouge C, Guinebretiere JM, Contesso G, Di Paola R, Blery M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994;29:1043-9.
21. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-63.
22. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Eng J Med 1991;324:1-8.
23. Hawighorst H, Weikel W, Knapstein PG, et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 1998;4:2305-12. (Pubitemid 28477893)
24. Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 1997;57:4777-86. (Pubitemid 27468984)
25. Shih TT, Hou HA, Liu CY, et al. Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival. Blood 2009;113:3161-7.
26. Henson DE, Ries L, Freedman LS, Carriaga M. Relationship among outcome, stage of disease, and histologic grade for 22616 cases of breast cancer. The basis for a prognostic index. Cancer 1991;68:2142-9.
27. Carter CL, Allen C, Henson DE. Relation of tumour size, lymph node status and survival in 24740 breast cancer cases. Cancer 1989;63:181-7. (Pubitemid 19032001)
28. Giordano SH. Update on locally advanced breast cancer. Oncologist 2003;8:521-30. (Pubitemid 37467367)
29. McArdle CS, Crawford D, Dykes EH, et al. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 1986;73:264-76.
30. Touboul E, Buffat L, Belkacémi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1999;43:25-38. (Pubitemid 29068606)
31. McArdle CS, McMillan DC, Greenlaw N, Morrison DS. Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival. BMC Cancer 2010;3:398.
32. Rutqvist LE, Johansson H. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients. Acta Oncol 2006;45:517-27. (Pubitemid 44172627)